Showing 1 - 10 of 622
position of the US as a locus of innovation in pharmaceuticals has increased over the past decade compared to Europe. All in … in pharmaceuticals: 1) The size and the structure of the biomedical education and research systems; 2) Some basic …
Persistent link: https://www.econbiz.de/10005034968
In the present paper, it is attempted to empirically verify the impact of economic liberalization on the R&D behaviour of Indian pharmaceutical firms controlling for the effects of several firm specific characteristics including firm size. The results from the Tobit analysis for a sample of...
Persistent link: https://www.econbiz.de/10005109549
Much research has been carried out on the accumulation and effective use of knowledge as a companyspecific form of intellectual property. However, insufficient attention has been given to research focusing on the effects of micro-level knowledge absorption and its effective use. In this paper,...
Persistent link: https://www.econbiz.de/10011258775
In this paper, I compare activities in biotech firms in the two countries based on firm-level data in 2004 (443 Japanese firms, 12 of which are listed publicly, and 1,446 US firms, 431 of which are public). First, I found that Japanese firms are much smaller than US firms, even after controlling...
Persistent link: https://www.econbiz.de/10011071614
This paper reports on the findings of interviews conducted with Hungarian firms on their overall business and innovation strategies and innovation activities to pursue three interconnected aims: a) better understand firm behaviour by analysing qualitative features of innovation processes...
Persistent link: https://www.econbiz.de/10011108822
This paper is explorative in nature. Based on an empirical analysis of two different industrial settings (life sciences, LS; information and communication technologies, ICT), it investigates network growth and firm growth in networks. We find a remarkable correspondence between a few fundamental...
Persistent link: https://www.econbiz.de/10005034974
the 1990s. This enabled us to characterise several features of the innovation process in pharmaceuticals, particularly the …
Persistent link: https://www.econbiz.de/10005034980
We draw on diverse data sets to compare the institutional organization of upstream life science research across the United States and Europe. Understanding cross-national differences in the organization of innovative labor in the life sciences requires attention to the structure and evolution of...
Persistent link: https://www.econbiz.de/10005034989
. Foreign-owned firms tend to be large, and thus the decisive share of BERD is performed by large enterprises. Pharmaceuticals … past fifteen years as foreign pharmaceuticals firms became majority owners in most companies, pursuing global R …
Persistent link: https://www.econbiz.de/10011113727
distinction seems to emerge. On the one hand, systems that rely on market-based competition in pharmaceuticals promote a clear …
Persistent link: https://www.econbiz.de/10005034975